Materialise NV

MTLS·NasdaqGS·Technology
Compare
7.32+0.20 (+2.81%)today
At close: Nov 4, 4:00 PM EST · May be delayed up to 15 min · USD

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close7.12
Open7.20
Day range7.137.43
52-week range4.788.82
Off day high−1.48%
Off 52-week high−17.01%
Volume110.19K
Avg. volume (3M)193.45K
Market cap417.97M
EPS (TTM)0.2600
Forward P/E28.33
P/E ratio (TTM)28.15
Dividend yield—
Beta (5Y)1.30
Shares outstanding57.10M
Short interest2.35% of float
Earnings dateOct 28, 2026
Analyst target10.04
Profit margin4.64%

Against its peers

Compare in full ›
MTLS PDFS MUM.F CSH.DE 053980.KQ 0HB4.IL
Market cap 417.97M 1.68B 568.16M 81.74M 42.02B 35.51B
P/E (TTM) 28.2 159.2 18.0 12.1 — 33.9
Forward P/E 28.3 24.1 14.5 9.5 — 22.9
Price/book 1.5 4.5 8.0 1.6 — 4.6
Dividend yield — — 5.96% — 6.77% 0.62%
1-year change +24.91% +44.74% −19.06% +16.57% −35.14% +6.97%
Today +2.81% −5.69% +0.15% −1.93% 0.00% +5.03%

The closest companies by business and industry (Software - Application). Prices may be delayed up to 20 min.

Latest news

All MTLS news ›
Stock Titan·Negative

Materialise Q3 2026 net profit falls to €1.38M

SEGG Media Reports More Than 1,500% Year-Over-Year Revenue Growth in Second Quarter, Driven by Veloce uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the…

Stock Titan·Positive

Materialise buys back 184,068 shares for €1.19M

uniQure Announces FDA Acceptance and Priority Review of the Biologics License Application for ifezuntirgene inilparvovec for the Treatment of Huntington’s Disease Palantir Reports Q3 2026 U.S. Comm Revenue Growth of 148% Y/Y and Revenue…

Seeking Alpha·

Materialise NV 2026 Q3 - Results - Earnings Call Presentation

2026-10-31. The following slide deck was published by Materialise NV in conjunction with their 2026 Q3 earnings call. The following slide deck was published by Materialise NV in conjunction with their 2026 Q3 earnings call. Q3: 2026-10-28…

Markets Daily·

Materialise Q3 Earnings Call Highlights

Posted by Danessa Lincoln on Oct 31st, 2026 Materialise (NASDAQ:MTLS) reported third-quarter 2026 revenue growth led by its medical business, while higher research and development spending and one-time costs weighed on operating…

From the 4Search news index, newest first.

In the news

12mentions in 30 days
12with it in the headline
Mixedsentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 12 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance